National Immunisation Program Vaccinations in Pharmacy (NIPVIP) and State-funded Programs
The National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program is a Commonwealth funded program allowing eligible people to access free National Immunisation Program (NIP) vaccines from Queensland Health registered Pharmacy Immunisation Service Providers (ISPs) with no out-of-pocket costs.
More information, including program rules and reimbursement rates can be found at National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program - Pharmacy Programs Administrator
Understanding the Immunisation Schedule Queensland
The NIP schedule outlines the series of vaccines given from birth through to adulthood. The Queensland Government funds some additional immunisations to what is included on the NIP schedule. The Immunisation Schedule Queensland outlines both NIP and state-funded immunisations, therefore, Queensland Pharmacy ISPs should refer to this to ensure that eligibility is appropriately considered for people living in Queensland. Eligibility for state-funded programs is not linked to Medicare eligibility.
The Australian Immunisation Handbook may recommend immunisations for some cohorts not funded under the NIP or State-funded programs. This may include immunisations for travel or occupational risks. Government funded immunisations supplied by the Queensland Health Immunisation Program (QHIP) cannot be administered for cohorts not eligible under the NIP or the Immunisation Schedule Queensland. Pharmacists will need to procure the stock privately.
Registering with Queensland Health as a Pharmacy Immunisation Service Provider
You can submit any enquiries about registering as a Pharmacy ISP by emailing QHIP-ADMIN@health.qld.gov.au.
Ordering NIP and state-funded immunisations
Queensland pharmacy ISPs can order NIP and state-funded immunisations from the Queensland Health Immunisation Program (QHIP), providing they have an approved Queensland Health Immunisation Management Protocol (IMP). Pharmacies that are not registered as an ISP and do not have an approved IMP will not be able to order funded immunisations.
Your local Public Health Unit (PHU) provides guidance and support for all immunisation management activities, covering both NIP and state-funded vaccine programs. The PHU will be responsible for reviewing and approving your IMP.
Refer to the Public Health Units page for contact details and further information.
Reporting Adverse Events Following Immunisation (AEFI) and Vaccine Administration Errors (VAEs)
Under the Public Health Act 2005, adverse events following immunisation (AEFI) are a notifiable condition. It is important that all AEFI are reported, particularly if serious or unexpected, as this will enable safety issues to be identified and managed appropriately as soon as possible.
Vaccination administration errors (VAEs) can occur due to errors in product preparation, handling, storage or administration and can be associated with immunisation error-related reactions. Identification and follow-up of VAEs can identify and correct immunisation error-related reactions in a timely manner and are essential to ensure the quality and safety of a vaccination service.
For more information, including how to report AEFIs and VAEs, visit the Adverse event following immunisation | Queensland Health webpage.
Providing offsite immunisation
From 1 March 2026 changes to Queensland’s medicines legislation have removed the location restrictions for pharmacists delivering immunisation services. Pharmacists should consider the location they are providing immunisation in to ensure that it is safe and appropriate for the delivery of this service.
Queensland pharmacy ISPs registered with QHIP must also ensure their IMP is updated with their local PHU to reflect any outreach models provided using NIP or state-funded vaccine stock.
Location restrictions for claiming under the NIPVIP will remain as this is an Australian Government program (national) and is not affected by state or territory legislation. Refer to the National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program - Pharmacy Programs Administrator webpage for more information relating to NIPVIP program rules.
Summary of reimbursement available to Queensland community pharmacies
Queensland offers the following state-funded programs in addition to the NIP:
- Influenza (FluMist and Free Flu)
- Meningococcal B
- Measles
- RSV (infants)
- JEV
- Mpox
- Diphtheria
The table at the bottom of this page provides a summary of the funding available to pharmacies in Queensland.
Queensland pharmacies may seek reimbursement from Queensland Health for the following state-funded programs:
- Meningococcal B see Queensland MenB Vaccination Program
- Influenza (see 2026 Free Flu Vaccination Program and 2026 Queensland Nasal Spray Flu Immunisation Program for more information relating to reimbursement for these programs)
Stock for state-funded and NIP programs should be obtained from QHIP, and where reimbursement for NIP or state-funded programs is not available, pharmacists may choose to charge an administration fee. Pharmacies should not use private stock for state funded programs.
Refer to the table below for more information relating to available reimbursement for pharmacies.
Where reimbursement for NIP or state-funded programs is not available, pharmacists may choose to charge an administration fee.
| Vaccine Type (current as at 20/03/2026) | Where to claim reimbursement | Reimbursement per vaccine administered |
|---|---|---|
| NIP 6 months to <5 years | Queensland Health | $20.05 (program commences 1 March 2026) |
| NIP 5 years and over in a pharmacy setting, a RACF or a disability home | Commonwealth (NIPVIP) | Refer to the Pharmacy Programs Administrator NIPVIP page |
| NIP influenza administered in all other non-pharmacy settings not included above | Queensland Health | $20.05 (program commences 1 March 2026) |
| Queensland funded FluMist for all children aged 2 to 5 years (inclusive) | Queensland Health | $20.05 (program commences 1 March 2026) |
| Queensland funded FluMist for children aged 6 to 17 years (inclusive) who struggle with getting a needle | Queensland Health | $20.05 (program commence 19 May 2026) |
| Private Market Influenza (all brands) | Queensland Health | $25 (program commences 1 March 2026) |
| Vaccine Type (current as at 20/03/2026) | Where to claim reimbursement | Reimbursement per vaccine administered |
|---|---|---|
| Infants to 12 months and catch-ups for 12 months to <2 years old (where not NIP eligible) | Queensland Health | $20.05 |
| Adolescents (15-19 years old) | Queensland Health | $20.05 |
| NIP Meningococcal B | Commonwealth (NIPVIP) | $20.05 |
| Vaccine Type (current as at 20/03/2026) | Where to claim reimbursement | Reimbursement per vaccine administered |
|---|---|---|
| MM*1-7 | Commonwealth | $20.05 |
| Vaccine Type (current as at 20/03/2026) | Where to claim reimbursement | Reimbursement per vaccine administered |
|---|---|---|
| NIP (<5 years) | Nil reimbursement available | - |
| NIP (5 years and over) | Commonwealth (NIPVIP) | $20.05 |
Queensland MMR Program
| Nil reimbursement available | May use QHIP funded vaccine and charge an administration fee. |
| Vaccine Type (current as at 20/03/2026) | Where to claim reimbursement | Reimbursement per vaccine administered |
|---|---|---|
| Maternal RSV (Abrysvo®) | Commonwealth (NIPVIP) | $20.05 |
| Infant RSV (nirsevimab) | Nil reimbursement available | - |
| Vaccine Type (current as at 20/03/2026) | Where to claim reimbursement | Reimbursement per vaccine administered |
|---|---|---|
| Japanese Encephalitis Virus Vaccine (Imojev/JEspect) | Nil reimbursement available | - |
| Vaccine Type (current as at 20/03/2026) | Where to claim reimbursement | Reimbursement per vaccine administered |
|---|---|---|
| Mpox (Jynnoes) | Nil reimbursement available | - |
| Vaccine Type (current as at 22/05/2026) | Where to claim reimbursement | Reimbursement per vaccine administered |
|---|---|---|
|
State funded diphtheria containing vaccine for Aboriginal and Torres Strait Islander people | Nil reimbursement available | - |
| NIP Diphtheria containing vaccine | Commonwealth (NIPVIP) | $20.05 |
| Vaccine Type (current as at 20/03/2026) | Where to claim reimbursement | Reimbursement per vaccine administered |
|---|---|---|
| 5 years and over (where administered in a pharmacy setting, a RACF or a disability home | Commonwealth (NIPVIP) | $20.05 |
| <5 years old (or >5 years outside of a pharmacy setting, a RACF or a disability home) | Nil reimbursement available | - |
Program enquiries
For further information, please email immunisation@health.qld.gov.au
Additional information
Legislation, standards and extended practice authorities | Queensland Health
The Australian Immunisation Handbook | Australian Government Department of Health and Aged Care
Using the Australian Immunisation Register (AIR) | Queensland Health
Order, store and manage vaccines | Queensland Health
National Immunisation Program Schedule | Australian Government Department of Health and Aged Care
2026 Free Flu Vaccination Program | Queensland Health